You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.
|
|---|---|
| Published in |
Journal of Clinical Oncology, March 2019
|
| DOI | 10.1200/jco.18.02236 |
| Pubmed ID | |
| Authors |
Alice T Shaw, Benjamin J Solomon, Benjamin Besse, Todd M Bauer, Chia-Chi Lin, Ross A Soo, Gregory J Riely, Sai-Hong Ignatius Ou, Jill S Clancy, Sherry Li, Antonello Abbattista, Holger Thurm, Miyako Satouchi, D Ross Camidge, Steven Kao, Rita Chiari, Shirish M Gadgeel, Enriqueta Felip, Jean-François Martini |
X Demographics
The data shown below were collected from the profiles of 64 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 22% |
| Spain | 8 | 13% |
| France | 4 | 6% |
| United Kingdom | 3 | 5% |
| Australia | 3 | 5% |
| Japan | 2 | 3% |
| Mexico | 2 | 3% |
| Italy | 2 | 3% |
| Canada | 2 | 3% |
| Other | 5 | 8% |
| Unknown | 19 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 34 | 53% |
| Scientists | 15 | 23% |
| Practitioners (doctors, other healthcare professionals) | 11 | 17% |
| Science communicators (journalists, bloggers, editors) | 3 | 5% |
| Unknown | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 207 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 207 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 35 | 17% |
| Other | 24 | 12% |
| Student > Ph. D. Student | 22 | 11% |
| Student > Bachelor | 16 | 8% |
| Student > Postgraduate | 15 | 7% |
| Other | 34 | 16% |
| Unknown | 61 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 76 | 37% |
| Biochemistry, Genetics and Molecular Biology | 26 | 13% |
| Agricultural and Biological Sciences | 5 | 2% |
| Chemistry | 4 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 1% |
| Other | 15 | 7% |
| Unknown | 78 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 83. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2024.
All research outputs
#521,389
of 25,761,363 outputs
Outputs from Journal of Clinical Oncology
#1,073
of 22,239 outputs
Outputs of similar age
#11,800
of 365,275 outputs
Outputs of similar age from Journal of Clinical Oncology
#24
of 206 outputs
Altmetric has tracked 25,761,363 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,239 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 206 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.